SuperGen Bleeds a Little Less



Officials with the Dublin-based biotech firm SuperGen announced that the company is losing less money than it did last year! Woo hoo. According to the East Bay Biz Times, SuperGen only lost $1.1 million last quarter, compared with bleeding $3.3 million for the same period in 2007. But SuperGen expects to shell out an additional $5 million in 2008, stemming from an earlier acquisition. Let's hear it for staying alive!